Android app on Google Play

After-Hours Stock Movers 8/21: (OGXI) (GME) (TFM) Higher; (BORN) (ARO) (MENT) Lower (more...)

August 21, 2014 5:57 PM EDT Send to a Friend

China New Borun Corp. (NYSE: BORN) 10.7% LOWER; reported Q2 EPS of $0.13. Revenue for the quarter came in at $108.7 million. See Q3 revenue of million $84.5 million to $87.8 million.

Aeropostale, Inc. (NYSE: ARO) 8.7% LOWER; reported Q2 EPS of ($0.46), $0.13 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $396.2 million versus the consensus estimate of $392.61 million. Comparable sales, including the e-commerce channel, for the second quarter of fiscal 2014 decreased 13%, compared to a decrease of 15% for the corresponding 13-week period ended August 3, 2013. Aeropostale, Inc. sees Q3 2014 EPS of ($0.48) - ($0.44), versus the consensus of ($0.33).

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) 7.9% HIGHER; announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC), is continuing as planned per the recommendation of the Independent Data Monitoring Committee (IDMC) based upon completion of the first interim futility analysis.

GameStop Corp. (NYSE: GME) 7.1% HIGHER; reported Q2 EPS of $0.22, $0.04 better than the analyst estimate of $0.18. Revenue for the quarter came in at $1.73 billion versus the consensus estimate of $1.64 billion. Consolidated comparable store sales increased 21.9%. GameStop Corp. sees Q3 2014 EPS of $0.58-$0.64, versus the consensus of $0.57.

The Fresh Market, Inc. (NASDAQ: TFM) 6.5% HIGHER; reported Q2 EPS of $0.36, $0.01 better than the analyst estimate of $0.35. Revenue for the quarter came in at $422.2 million versus the consensus estimate of $411.85 million. Comparable store sales increased 2.9%. The Fresh Market, Inc. reaffirmed FY2014 guidance.

Ross Stores, Inc. (NASDAQ: ROST) 6.2% HIGHER; reported Q2 EPS of $1.14, $0.06 better than the analyst estimate of $1.08. Revenue for the quarter came in at $2.73 billion versus the consensus estimate of $2.71 billion. Ross Stores, Inc. sees FY2014 EPS of $4.18-$4.26, versus prior guidance of $4.09-$4.21 and the consensus of $4.21. Ross Stores, Inc. sees Q3 2014 EPS of $0.83-$0.87, versus the consensus of $0.86.

Qunar (NASDAQ: QUNR) 5.1% HIGHER; reported Q2 EPS of ($0.57), $0.32 worse than the analyst estimate of ($0.25). Revenue for the quarter came in rose 127.3% to $64.5 million versus the consensus estimate of $56.03 million.

Mentor Graphics Corp (NASDAQ: MENT) 3.4% LOWER; reported Q2 EPS of $0.23, $0.08 better than the analyst estimate of $0.15. Revenue for the quarter came in at $260.2 million versus the consensus estimate of $253.55 million. Mentor Graphics Corp sees Q3 2015 EPS of $0.21, versus the consensus of $0.39. Mentor Graphics Corp sees Q3 2015 revenue of $275 million, versus the consensus of $297.9 million. Mentor Graphics Corp sees FY2015 EPS of $1.75, versus the consensus of $1.76. Mentor Graphics Corp sees FY2015 revenue of $1.237 billion, versus the consensus of $1.24 billion.

TravelCenters of America (NYSE: TA) 3.5% HIGHER; reported Q1 EPS of $0.01, $0.20 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.97 billion versus the consensus estimate of $2.02 billion.

Tuesday Morning Corp (NASDAQ: TUES) 3.4% HIGHER; reported Q4 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $212.6 million versus the consensus estimate of $213.11 million.

Brocade Communications (NASDAQ: BRCD) 2.3% HIGHER; reported Q3 EPS of $0.23, $0.04 better than the analyst estimate of $0.19. Revenue for the quarter came in at $545 million versus the consensus estimate of $534.71 million.

ScanSource, Inc. (NASDAQ: SCSC) 1.9% HIGHER; reported Q4 EPS of $0.94, or $0.60 non-GAAP, both better than the analyst estimate of $0.59. Revenue for the quarter came in at $758.1 million versus the consensus estimate of $740.03 million. ScanSource, Inc. sees Q1 2015 EPS of $0.59-$0.61, versus the consensus of $0.66. ScanSource, Inc. sees Q1 2015 revenue of $750-770 million, versus the consensus of $755.99 million. The Company also announced a $120 million authorization by its Board of Directors to repurchase shares of the Company’s common stock over three years.

Isis Pharma (Nasdaq: ISIS) 1.8% HIGHER; On August 21, 2014, the first infant received their first dose of ISIS-SMNRx in the Isis Pharma (Nasdaq: ISIS) Phase 3 study, ENDEAR, which is evaluating ISIS-SMNRx in infants with spinal muscular atrophy (SMA). Isis earned an $18 million milestone payment from its development partner, Biogen Idec International Holding Ltd as a result of Isis’ achievement of this milestone event. The ENDEAR study, is the first Phase 3 clinical study for ISIS-SMNRx. Isis plans to initiate a second pivotal study in children with SMA later this year and additional studies are in the planning stages. Additional information regarding the ENDEAR study may be found at the following website:

Marvell Technology Group (NASDAQ: MRVL) 1.3% LOWER; reported Q2 EPS of $0.34, $0.06 better than the analyst estimate of $0.28. Revenue for the quarter came in at $961.5 million versus the consensus estimate of $961.56 million. Marvell Technology Group sees Q3 2014 EPS of $0.29, versus the consensus of $0.32. Marvell Technology Group sees Q3 2014 revenue of $960-1000 million, versus the consensus of $1010 million.

Gap, Inc. (NYSE: GPS) 1.1% HIGHER; reported Q2 EPS of $0.74, $0.05 better than the analyst estimate of $0.69. Revenue for the quarter came in at $3.98 billion versus the consensus estimate of $3.97 billion. Gap, Inc. sees FY2014 EPS of $2.95-$3.00, versus the consensus of $2.95.

Salesforce.com, Inc. (NYSE: CRM) 0.5% HIGHER; reported Q2 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.29 billion.





You May Also Be Interested In


Related Categories

Special Reports

Related Entities

After-Hours Movers

Add Your Comment